HK1065719A1 - Use of thrombin-derived peptides for the therapy of chronic dermal ulcers - Google Patents

Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Info

Publication number
HK1065719A1
HK1065719A1 HK04108700A HK04108700A HK1065719A1 HK 1065719 A1 HK1065719 A1 HK 1065719A1 HK 04108700 A HK04108700 A HK 04108700A HK 04108700 A HK04108700 A HK 04108700A HK 1065719 A1 HK1065719 A1 HK 1065719A1
Authority
HK
Hong Kong
Prior art keywords
thrombin
therapy
chronic dermal
derived peptides
dermal ulcers
Prior art date
Application number
HK04108700A
Other languages
English (en)
Inventor
Darrell H Carney
Original Assignee
Orthologic Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Orthologic Corp filed Critical Orthologic Corp
Publication of HK1065719A1 publication Critical patent/HK1065719A1/xx

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00Medicinal preparations containing peptides
    • A61K38/16Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43Enzymes; Proenzymes; Derivatives thereof
    • A61K38/46Hydrolases (3)
    • A61K38/48Hydrolases (3) acting on peptide bonds (3.4)
    • A61K38/482Serine endopeptidases (3.4.21)
    • A61K38/4833Thrombin (3.4.21.5)
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00Drugs for dermatological disorders
    • A61P17/02Drugs for dermatological disorders for treating wounds, ulcers, burns, scars, keloids, or the like
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/08Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Chemical & Material Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Medicinal Chemistry (AREA)
  • Diabetes (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Gastroenterology & Hepatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Epidemiology (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Immunology (AREA)
  • Obesity (AREA)
  • Dermatology (AREA)
  • Emergency Medicine (AREA)
  • Endocrinology (AREA)
  • Hematology (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Peptides Or Proteins (AREA)
HK04108700A 2001-07-27 2004-11-05 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers HK1065719A1 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
US30819801P 2001-07-27 2001-07-27
PCT/US2002/001151 WO2003013569A2 (en) 2001-07-27 2002-01-16 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Publications (1)

Publication Number Publication Date
HK1065719A1 true HK1065719A1 (en) 2005-03-24

Family

ID=23192964

Family Applications (1)

Application Number Title Priority Date Filing Date
HK04108700A HK1065719A1 (en) 2001-07-27 2004-11-05 Use of thrombin-derived peptides for the therapy of chronic dermal ulcers

Country Status (12)

Country Link
US (3) US7049294B2 (zh)
EP (1) EP1414487B1 (zh)
JP (1) JP4192093B2 (zh)
CN (1) CN100509055C (zh)
AT (1) ATE328606T1 (zh)
AU (1) AU2002236768B2 (zh)
CA (1) CA2455756C (zh)
DE (1) DE60212143T2 (zh)
DK (1) DK1414487T3 (zh)
ES (1) ES2271216T3 (zh)
HK (1) HK1065719A1 (zh)
WO (1) WO2003013569A2 (zh)

Families Citing this family (15)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP4192093B2 (ja) * 2001-07-27 2008-12-03 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 慢性皮膚潰瘍の治癒を促進する方法
DE60313982T2 (de) * 2002-07-02 2008-01-17 Orthologic Corp., Tempe Dimere von thrombinpeptidderivaten
AU2003256343B2 (en) * 2002-07-02 2006-12-21 Orthologic Corp. Thrombin peptide derivatives
ATE357928T1 (de) 2003-12-31 2007-04-15 Orthologic Corp Pharmazeutische zusammensetzung für thrombinpeptidderivaten
WO2007035406A1 (en) * 2005-09-16 2007-03-29 Orthologic Corp. Antibodies to complementary peptides of thrombin or portions thereof
US20100330028A1 (en) * 2007-04-10 2010-12-30 The Board Of Regents The Universityof Texas System Combination therapy for chronic dermal ulcers
EP2268304A2 (en) * 2008-03-26 2011-01-05 Orthologic Corp. Methods for treating acute myocardial infarction
WO2009120300A2 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating degenerative diseases
US20110117075A1 (en) * 2008-03-26 2011-05-19 Orthologic Corp. Thrombin derived peptides for smooth muscle relaxation
CA2722620A1 (en) * 2008-03-26 2009-10-01 Orthologic Corp. Method of treating peripheral arterial disease
GB0916576D0 (en) 2009-09-22 2009-10-28 Malmsten Nils M Polypeptides and uses thereof
WO2011104702A1 (en) * 2010-02-24 2011-09-01 Syneron Medical Ltd. A body contouring apparatus
US8806615B2 (en) 2010-11-04 2014-08-12 Mcafee, Inc. System and method for protecting specified data combinations
US10220078B2 (en) 2014-06-11 2019-03-05 The Board Of Regents Of The University Of Texas System Methods of using thrombin derivatives to treat medulloblastoma
CZ308845B6 (cs) * 2019-01-21 2021-07-07 Globetech Innovation S.R.O Farmaceutická směs topicky hojivých peptidových složek pro použití k topické léčbě kožních defektů a/nebo k topickému hojení ran

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5352664A (en) 1986-10-31 1994-10-04 Board Of Regents, The University Of Texas System Thrombin derived polypeptides; compositions and methods for use
AU5638096A (en) 1995-06-07 1996-12-30 Clarion Pharmaceuticals, Inc. Non-biological patch for hemostasis
GB9930768D0 (en) * 1999-12-29 2000-02-16 Pfizer Ltd Composition
JP4192093B2 (ja) * 2001-07-27 2008-12-03 ザ ボード オブ リージェンツ オブ ザ ユニバーシティ オブ テキサス システム 慢性皮膚潰瘍の治癒を促進する方法

Also Published As

Publication number Publication date
CN1556711A (zh) 2004-12-22
EP1414487A2 (en) 2004-05-06
US7049294B2 (en) 2006-05-23
EP1414487B1 (en) 2006-06-07
JP4192093B2 (ja) 2008-12-03
US20060241049A1 (en) 2006-10-26
WO2003013569A3 (en) 2003-12-11
US20040209819A1 (en) 2004-10-21
CA2455756A1 (en) 2003-02-20
ES2271216T3 (es) 2007-04-16
CA2455756C (en) 2013-04-02
DE60212143T2 (de) 2007-04-12
DK1414487T3 (da) 2006-10-09
CN100509055C (zh) 2009-07-08
AU2002236768B2 (en) 2006-06-08
JP2004538320A (ja) 2004-12-24
US7378500B2 (en) 2008-05-27
US20090029923A1 (en) 2009-01-29
US7833982B2 (en) 2010-11-16
DE60212143D1 (de) 2006-07-20
ATE328606T1 (de) 2006-06-15
WO2003013569A2 (en) 2003-02-20

Similar Documents

Publication Publication Date Title
HK1065719A1 (en) Use of thrombin-derived peptides for the therapy of chronic dermal ulcers
TWI345978B (en) Combination therapy comprising glucose reabsorption inhibitors and retinoid x receptor modulators
MY180762A (en) Combination therapy comprising glucose reabsorption inhibitors and ppar modulators.
UA88500C2 (ru) Многослойная повязка, пригодная для сокращения продолжительности процесса заживления ран
PL368683A1 (en) A wound dressing
DE60209813D1 (de) Hydrogelschicht enthaltender, absorbierender wundverband
AU3802900A (en) A pressure relieving dressing
DK1349856T3 (da) Isoindolin-1-on-glucokinase-aktivatorer
ATE358510T1 (de) Vorrichtung zur iontophoretischen verabreichung von medikamenten durch das augenlid
NO20053042L (no) Anvendelse av spongosin (2-metoksyadenosin) for behandling av smerte, saerlig hyperalgesi.
WO2006114105A3 (en) Use of modified factor vii for treating bleeding
WO2001078703A3 (en) Methods and compositions for modulating alpha adrenergic receptor activity
SE0003537L (sv) Hudvänligt lim
AU2003207706A1 (en) Durable, liquid impermeable and moisture vapor permeable carpet pad
DE60221884D1 (de) Mediziniscer verband
NO992674D0 (no) Konturen til et transdermalt terapeutisk system
WO2002024181A3 (en) The use of melatonin for induction of general anesthesia
WO2001005445A3 (en) A carbon dioxide generating device for medical treatment
WO2002072032A3 (en) Compounds and methods for identifying, staging and treating cutaneous t-cell lymphoma
WO2003070177A3 (en) Use of melatonin analogues for induction of general anesthesia
SE0101725L (sv) Förbandshållare
WO1996007421A3 (en) An antiulcer medicine comprising a protein possessing all growth factor activity and a proton pump inhibitor
AU2002325228A1 (en) Skin adhesive dressing comprising a light-emitting or radiation-emitting device, and method for the use thereof
UA34377A (uk) Спосіб терапії астенічного синдрому у хворих на хронічний алкоголізм
AU2003294101A1 (en) Method for oligomerization of molecules, device therefor and use thereof

Legal Events

Date Code Title Description
PC Patent ceased (i.e. patent has lapsed due to the failure to pay the renewal fee)

Effective date: 20140116